Does MIDOSTAURIN Cause Therapy non-responder? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Therapy non-responder have been filed in association with MIDOSTAURIN (RYDAPT). This represents 0.7% of all adverse event reports for MIDOSTAURIN.
22
Reports of Therapy non-responder with MIDOSTAURIN
0.7%
of all MIDOSTAURIN reports
6
Deaths
3
Hospitalizations
How Dangerous Is Therapy non-responder From MIDOSTAURIN?
Of the 22 reports, 6 (27.3%) resulted in death, 3 (13.6%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIDOSTAURIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does MIDOSTAURIN Cause?
Death (397)
Nausea (252)
Febrile neutropenia (223)
Diarrhoea (194)
Pyrexia (188)
Acute myeloid leukaemia recurrent (171)
Pancytopenia (152)
Vomiting (152)
Drug ineffective (151)
Thrombocytopenia (140)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which MIDOSTAURIN Alternatives Have Lower Therapy non-responder Risk?
MIDOSTAURIN vs MIFEPRISTONE
MIDOSTAURIN vs MIGALASTAT
MIDOSTAURIN vs MIGLITOL
MIDOSTAURIN vs MIGLUSTAT
MIDOSTAURIN vs MILNACIPRAN